Pain, Burning Recruiting Phase 3 Trials for Ketamine (DB01221)

IndicationStatusPhase
DBCOND0044609 (Pain, Burning)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02860117Ketamine Continuous Infusion on Opioid Consumption and Pain Management in Severe Burned PatientsTreatment